Botulinum toxin: beyond cosmesis.
Klein
A W
AW
Glogau
R G
RG
D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D003014:Clostridium botulinum / Q000145:classification / Q000472:pathogenicity; D003879:Dermatologic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D006801:Humans; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use; D012703:Serotyping
D003879:Dermatologic Agents; D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A